TREATMENT OF HYPERPROLIFERATIVE DISEASE WITH SUPERANTIGENS IN COMBINATION WITH ANOTHER ANTICANCER AGENT
Application 631/CHENP/2007 published 2007-08-24, filed 2007-02-13
Abstract The present invention relates to methods of treating mammals affected by. for example, a hyperproliferative disease such as cancer, by administering a tumor targeted superantigen and a chemotherapeutic agent, whereby the administration of the tumor-targeted superantigen and chemotherapeutic agent reduce the antibody response and enhance the T cell response. The superantigen, wild-type or modified, is fused to a target-seeking moiety, such as an antibody or an antibody active fragment. The combined administration of a superantigen and a chemotherapeutic agent provides enhanced therapeutic effects in a treated animal.
Applicant
1)ACTIVE BIOTECH AB
:724, S-220 07 LUND, SWEDEN Sweden
Inventor
1)HEDLUND, GUNNAR 2)FORSBERG, GORAN 3)WALLEN-OHMAN, MARIE
International Info
Classification: C07K 14/31
Publication Number: WO 2006/015882 A2
Application Date: 2005-08-12
Priority Information
0402025-1 Sweden 2004-08-13